郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

代谢疾病Synthesis and biological evaluation of novel tetrahydroisoquinoline-C-aryl glucosides as SGLT2 inhibitors for the treatment of type 2 diabetes.

期刊：European journal of medicinal chemistry发表年份：2016作者：Xuan Pan; Yi Huan; Zhufang Shen; Zhanzhu Liu
阅读更多 →

代谢疾病SP6616 as a new Kv2.1 channel inhibitor efficiently promotes β-cell survival involving both PKC/Erk1/2 and CaM/PI3K/Akt signaling pathways.

期刊：Cell death & disease发表年份：2016作者：T T Zhou; L L Quan; L P Chen; T Du; K X Sun; J C Zhang; L Yu; Y Li; P Wan; L L Chen; B H Jiang; L H Hu; J Chen; X Shen
阅读更多 →

代谢疾病Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain.

期刊：Journal of medicinal chemistry发表年份：2016作者：Herbert H Seltzman; Craig Shiner; Erin E Hirt; Anne F Gilliam; Brian F Thomas; Rangan Maitra; Rod Snyder; Sherry L Black; Purvi R Patel; Yatendra Mulpuri; Igor Spigelman
阅读更多 →

代谢疾病Synthesis and biological evaluation of novel dioxa-bicycle C-aryl glucosides as SGLT2 inhibitors.

期刊：Carbohydrate research发表年份：2016作者：Qi Yan; Ning Ding; Yingxia Li
阅读更多 →